E V Panfilova | AMiner学者主页

全面呈现 [E V Panfilova] 的学术影响力

深度挖掘高质量成果与权威引用，让优秀看得见

论文（5）

专利

基金项目

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1РАЗРАБОТКА И ВНЕДРЕНИЕ НОВЫХ МЕТОДОВ ЛЕЧЕНИЯ ОСТРОГО КОРОНАРНОГО СИНДРОМА

в а марков,и в максимов,в в рябов,а н репин,е в вышлов,т м попонина,т е суслова,а г сыркина,м в балахонова,с в демьянов,а л крылов,с и антипов,

2007引用：23

引用

AI阅读

2Разработка И Внедрение Новых Методов Лечения Острого Коронарного Синдрома

В. А. Марков,И. В. Максимов, В,А. Н. Репин,Е. В. Вышлов,Т. М. Попонина,Т. Е. Суслова,А. Г. Сыркина,М. В. Балахонова,С. В. Демьянов,А Л Крылов,С. И. Антипов,

Urgent cardiology department of Tomsk research cardiology institute discussed new acute coronary syndrome treatment approaches. Accelerated intravenous 10-15 minutes Streptokinase infusion is favorable modified times delay up to coronary artery reperfusion in myocardial infarction patients. This method had high safety and coronary artery opening rate. Prognosis of serious adverse events in elder patient was depended from myocardial necrosis extend, but not from thrombolythic therapy execution. Pulmonary edema and cardiogenic shock development in MI patients were most high negative prognosis survival index. Early thrombolysis, PCI and their combination increased MI patients survival. Recovery of myocardial function is a new approach for congestive heart failure treatment in post MI patients. Autological mononuclear cell transplantation by its intracoronary infusion is studied in urgent cardiology department.

2007Сибирский журнал клинической и экспериментальной медицины

引用

AI阅读

3[Comparison of Efficacy of Bolus Injection and Drop Infusion of Streptokinase in Patients with Myocardial Infarction].

VA Markov,EV Vyshlov,EV Panfilova,IV Maximov,AN Repin,VA Shikankov,AL Krylov,RS Karpov

2002PubMed（2002）引用：24

引用

AI阅读

4The Efficacy Of Bolus Administration Of 750 000 Units Of Streptokinase In Ami Patients

Va Markov,Ev Vyshlov,Ev Panfilova,Iv Maximov

Bolus i.v. administration of streptokinase (SK) 750 000 U within 5-10 min in AMI patients results in earlier reperfusion of infarct-related artery at equal rate of its opening compared to standard method ( infusion of 1.5 million U of SK within 60 min). Thrombolytic therapy using bolus i.v. administration of SK 750 000 U results in decreased rate of hemorrhagic complications, increased rate of short-term arterial hypotension which is easily stopped as compared to infusion of SK 1.5 million U in drops.

2000CORONARY ARTERY DISEASE: PREVENTION TO INTERVENTION

引用

AI阅读

5[Aspirin Vs Ticlid and Their Combination in Patients with Acute Myocardial Infarction].

E V Vyshlov,E V Panfilova, V A Markov

ADP-induced platelet aggregation was studied in 28 patients with myocardial infarction randomized, at admission, into three groups. Conventional therapy with heparin and antianginal drugs was combined with aspirin (250 mg/day, n = 9), tiklid (500 mg/day, n = 9), tiklid (500 mg/day) + aspirin (250 mg/day, n = 10) in group 1, 2 and 3, respectively. Tiklid diminished platelet aggregation more effectively than aspirin on the disease day 7 and 21. Tiklid + aspirin combination suppresses platelet aggregation more than monotherapy with either of the drugs, provides insignificant attenuation of postinfarction angina but is associated with a high risk of hemorrhagic complications.

2000Klinicheskaia meditsina（2000）引用：23

引用

AI阅读

作者统计

No data

相似学者

Evgeny Viktorovich Vyshlov

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn